Everlasting Moisture With Juvéderm®’s Volite

With an unrivalled patented technology, Juvéderm®’s new Volite treatment leaves skin hydrated for up to nine months!16

Last year we were introduced to the new JUVÉDERM® Volite treatment that provides long-lasting1 moisture deep within the skin2. If you’re wondering how this is possible, we’ve got the low-down right here and it all begins with hyaluronic acid (HA).

Why hyaluronic acid?

With its unique ability to retain water, HA is the perfect match for dehydrated skin. While it is already present in the skin, ageing and exposure to external stressors may decrease the amount. This is where JUVÉDERM® Volite comes in to provide HA right into the dermis.

Vycross® technology

While other HA fillers use only high molecular weight HA, JUVÉDERM® Volite cross-links and combines a majority of low molecular weight HA with lesser high molecular weight HA3 to create fillers that are smoother and more efficient with its patented Vycross® technology. This allows for an effortless process, natural look and long-lasting moisture4-12.

The advantages:

Improves skin texture
The JUVÉDERM® Volite HA fillers delivered into the skin helps to stimulate collagen production13 which then reduces the appearance of fine lines, crepiness and rough skin textures.

Increases elasticity
Replenishing HA back into the skin helps to repair its moisture barrier and increase elasticity. This helps skin to restore itself back to its plump and youthful state14, 15.

Continuous moisture
As the HA fillers attract water, skin is kept hydrated for a longer period of time and it stays moisturised and radiant for up to nine months!16

Don’t miss this!
See how the treatment keeps Michelle Lee’s and Reem Shahwa’s skin constantly hydrated through their busy schedules:

For more info on JUVÉDERM® Volite, head over to www.juvederm.com.my

Ref: 1. Allergan DOF. INT/0297/2017. Juvéderm® Volite clinical study (V12-001) – 9 months topline results – summary. 2017. 2. Juvéderm® VOLITE DFU. 73140JR10. 3. 19.; 2. Bernardin A et al. Poster presentation at AMEC EMAA 2013. 4. Allergan Data on File INT/0297/2016. Juvéderm® VOLITE Clinical Study (V12-001), 9 months topline summary. Apr 2017. 5. Allergan Data on File INT/0654/2016(1). Juvéderm® VOLITE Clinical Study (V12-001), 9 months topline – hydration results. Feb 2017. 6. 6. Allergan Data on File INT/0652/2016(1). Juvéderm® VOLITE Clinical Study (V12-001), 9 months topline – Smoothness and elasticity. Feb 2017. 7. Callan P et al. Clin Cosmet Investig Dermatol. 2013; 6:81-9. 8. Bernardin A et al. Poster Presentation at Anti-Aging Medicine European Congress (AMEC), Monte Carlo; 2013. 9. Jones D and Murphy DK. Dermatol Surg. 2013; 39:1602–12. 10. Allergan Data on File. Volift 006. Jan 2015. 11. Allergan Data on File. Volift 003. Aug 2014. 12. Eccleston D and Murphy DK. Clin Cosmet Investig Dermatol. 2012; 5:167–72. 13. Allergan DOF INT0704.2016. 14. Allergan DOF INT/0444/2016(2). 15. Allergan DOF INT/0653/2016. 16. Allergan DOF. INT/0297/2017. Juvéderm® Volite clinical study (V12-001) – 9 months top line results – summary. 2017.
MY-JUV-1950035

, ,